Medicover AB (publ)

Informe acción OM:MCOV B

Capitalización de mercado: kr27.1b

Medicover Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Medicover de 41.4% y 14.1% por año respectivamente. Se prevé que el BPA crezca en un 37.4% al año. Se espera que la rentabilidad financiera sea de 19.4% en 3 años.

Información clave

38.2%

Tasa de crecimiento de los beneficios

40.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare31.8%
Tasa de crecimiento de los ingresos14.5%
Rentabilidad financiera futura18.6%
Cobertura de analistas

Low

Última actualización29 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30
Is Medicover (STO:MCOV B) Using Too Much Debt?

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30
Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17
Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Sep 09
Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Jul 25
Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Jul 12
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

Jun 13
Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

May 29
At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting

Apr 20
With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting

Medicover (STO:MCOV B) Could Easily Take On More Debt

Apr 08
Medicover (STO:MCOV B) Could Easily Take On More Debt

Medicover (STO:MCOV B) Is Doing The Right Things To Multiply Its Share Price

Mar 15
Medicover (STO:MCOV B) Is Doing The Right Things To Multiply Its Share Price

Is Now The Time To Look At Buying Medicover AB (publ) (STO:MCOV B)?

Feb 25
Is Now The Time To Look At Buying Medicover AB (publ) (STO:MCOV B)?

Previsiones de crecimiento de beneficios e ingresos

OM:MCOV B - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20262,725971453092
12/31/20252,353631222603
12/31/20242,03127922163
3/31/20241,82622113222N/A
12/31/20231,7461895205N/A
9/30/20231,682890205N/A
6/30/20231,610675202N/A
3/31/20231,548243186N/A
12/31/20221,5101230170N/A
9/30/20221,4893745182N/A
6/30/20221,4555967195N/A
3/31/20221,4428895205N/A
12/31/20211,377102115217N/A
9/30/20211,29993105202N/A
6/30/20211,2269091176N/A
3/31/20211,07652104176N/A
12/31/20209982683155N/A
9/30/20209301475141N/A
6/30/2020879453122N/A
3/31/20208841631100N/A
12/31/2019844232487N/A
9/30/2019796192879N/A
6/30/2019751193986N/A
3/31/2019709204085N/A
12/31/2018672223374N/A
9/30/2018643283475N/A
6/30/2018620262261N/A
3/31/2018600232055N/A
12/31/201758019N/A50N/A
9/30/201756010N/A40N/A
6/30/20175409N/A36N/A
3/31/20175226N/A31N/A
12/31/20164974N/A26N/A
12/31/20154168N/A29N/A
12/31/20143654N/A22N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (41.4% al año) de MCOV B es superior a la tasa de ahorro (0.9%).

Beneficios vs. Mercado: Se prevé que los beneficios (41.4% al año) de MCOV B crezcan más rápidamente que el mercado Swedish (13.1% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de MCOV B crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (14.1% al año) de MCOV B crezcan más rápidamente que los del mercado Swedish (1.5% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 14.1% al año) de MCOV B crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de MCOV B sea baja dentro de 3 años (19.4%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y